# Getting To A First Product Approval With Celcuity's Brian Sullivan Page: https://stenobird.com/podcast/business-of-biotech-123501/getting-to-a-first-product-approval-with-celcuity-s-brian-sullivan Text version: https://stenobird.com/podcast/business-of-biotech-123501/getting-to-a-first-product-approval-with-celcuity-s-brian-sullivan.md Podcast: [Business Of Biotech](https://stenobird.com/podcast/business-of-biotech-123501) Published: 2026-08-17T10:00:00+00:00 Episode link: https://www.buzzsprout.com/1011661/episodes/19636491-getting-to-a-first-product-approval-with-celcuity-s-brian-sullivan.mp3 Audio file: https://www.buzzsprout.com/1011661/episodes/19636491-getting-to-a-first-product-approval-with-celcuity-s-brian-sullivan.mp3 Processing state: not_requested JSON: https://stenobird.com/v1/public/podcasts/business-of-biotech-123501/episodes/getting-to-a-first-product-approval-with-celcuity-s-brian-sullivan Duration seconds: 3016 ## Resource We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Brian Sullivan, CEO at Celcuity, talks about winning the company's first FDA approval for Revtorpyk, a kinase inhibitor for breast cancer patients, and why targeting an “untreated disease mechanism” can beat chasing a single mutation. Brian also discusses the process for licensing a shelved Pfizer asset for development, designing Phase 3 trials that challenge assumptions, the benefits of... ## Actions - request_transcript: `POST https://stenobird.com/v1/public/podcasts/business-of-biotech-123501/episodes/getting-to-a-first-product-approval-with-celcuity-s-brian-sullivan/transcription-requests` — Idempotently request low-priority transcript generation for this episode. - read_markdown: `GET https://stenobird.com/podcast/business-of-biotech-123501/getting-to-a-first-product-approval-with-celcuity-s-brian-sullivan.md` — Read the agent-friendly Markdown representation of this episode resource. A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed. ## Transcript Full transcripts are not published on public pages unless there is a clear rights basis.